Summit Therapeutics SMMT Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $16.37M+0.6% | $16.26M+46.9% | $11.07M-82.2% | $62.09M-13.5% | ||
| $488.18M+58.8% | $307.49M+168% | $114.82M— | $0— | ||
| $720.3M+70.0% | $423.75M+123% | $189.71M-71.1% | $656.71M+575% | ||
| $1.06M+317% | $254K+24.5% | $204K-77.5% | $906K+30.5% | ||
| $2M+7.3% | $1.86M-1.5% | $1.89M+5.3% | $1.8M-10.5% | ||
| $751.18M+72.5% | $435.56M+115% | $202.95M-69.4% | $664.17M+486% | ||
| $20.29M+338% | $4.64M+73.8% | $2.67M+651% | $355K-91.9% | ||
| $72.99M+74.9% | $41.73M+105% | $20.41M-47.4% | $38.78M+51.4% | ||
| $92.32M+97.2% | $46.81M-62.6% | $125.26M-76.7% | $537.51M+1,686% | ||
| 1B+13,457% | 7.4M+5.1% | 7M+233% | 2.1M+115% | ||
| -$2.29B-88.9% | -$1.21B-22.3% | -$993.26M-163% | -$378.33M-26.3% | ||
| $658.86M+69.5% | $388.75M+400% | $77.69M-38.7% | $126.65M+52.1% | ||
| $751.18M+72.5% | $435.56M+115% | $202.95M-69.4% | $664.17M+486% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Summit Therapeutics's total assets?
- Summit Therapeutics (SMMT) holds $647.9M in total assets, up 68.8% year over year.
- How much debt does Summit Therapeutics have?
- Summit Therapeutics carries $20.0M in total debt against $545.9M of shareholders' equity, a debt-to-equity ratio of 0.04.
- How much cash does Summit Therapeutics have?
- Summit Therapeutics holds $8.2M in cash and equivalents.
- Can Summit Therapeutics cover its short-term obligations?
- Its current ratio is 7.41 — current assets exceed current liabilities.
- Where does Summit Therapeutics's balance sheet data come from?
- Every line is extracted from Summit Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.